Fig. 4.

a Ratio of GATA3⁺ cells to Tbet⁺ cells in the VSME in MEL48 and MEL55 both week 1 and week 7 after the first vaccine. b Ratio of CD8⁺ cells to FoxP3⁺ cells in the VSME in MEL48 and MEL55 both week 1 and week 7 after the first vaccine. For panels a and b, means and standard deviations are shown in addition to values for each sample. c Relative proportions of FoxP3⁺, Tbet⁺, and GATA3⁺ cells in the VSME dermis are shown for both trials and both time points. All p values have been corrected for false-discovery rate as stated in the methods and statistical significance was determined at p < 0.005